keytruda
New generation of cancer drugs challenges Keytruda
PD-1 inhibitors have revolutionized cancer treatment over the past decade, with Keytruda at the forefront as the world's best-selling drug. Now, however,...
BioInvent presents promising clinical data at ASCO and EHA
In the coming weeks, BioInvent will present...
BioInvent selected to present at ASCO in Chicago
BioInvent has been selected to present two posters...
BioInvent will soon have five drug candidates in six clinical studies
BioInvent has made a number of advances during the...
Major acquisition to strengthen Merck's immunology pipeline
It was recently announced that Merck is acquiring Prometheus...
Covid-19 products face tougher future
The value of patent protection in life science
To invent, develop and launch new medicines and...
Can Nordic companies extend the life of Keytruda?
Merck's cancer drug Keytruda is one of the best...
Evaxion recruits first patient in phase IIb melanoma study
Evaxion Biotech's lead immunotherapy candidate, EVX-01, developed through a...
Ultimovacs protects its cancer vaccine technology until 2037
Ultimovacs has received advance notice of an approved patent...
Issue takes Evaxion Biotech to Phase IIb studies
The third quarter of 2021 was eventful for Danish...
Evaxion Biotech will evaluate EVX-01 together with Merck & Co.
Copenhagen-based Evaxion Biotech develops drugs using...
Notes
Hansa Biopharma appoints new CMO
Perpetua Medical sells assets for SEK 10 million
Lipum reaches 89 percent subscription of warrants
EQL Pharma expands to Germany and the Netherlands
Oncopeptides Pepaxti included in European treatment guidelines
NEWSLETTER
NEWS
In the shadow of the GLP-1 hype: new report criticizes pharmaceutical companies' patent strategies
Five Nordic biotech stock market winners in H1 2025
Chugai and Gero in billion-dollar deal within AI
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
